McKesson Announces 2026 Annual Meeting Details and Board Leadership Changes
McKesson Corporation has filed its DEF 14A proxy statement, announcing its 2026 Annual Meeting of Shareholders to be held virtually on July 22, 2026. Key items of business include the election of 11 directors, ratification of Deloitte & Touche LLP as the independent auditor, and an advisory vote on executive compensation. The filing also details changes in Board leadership, with Brian S. Tyler becoming Chair of the Board and Dominic J. Caruso appointed as Lead Independent Director. The company highlights its 'Leadership Prescription' framework, focusing on people and culture, and its strategic priorities for advancing health outcomes.
Key Highlights
- McKesson announces its 2026 Annual Meeting of Shareholders will be held on July 22, 2026, virtually.
- Shareholders will vote on the election of 11 directors for a one-year term.
- The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year ending March 31, 2027, will be ratified.
- A non-binding advisory vote on executive compensation will be conducted.
- Brian S. Tyler assumes the role of Chair of the Board, effective May 1, 2026, with Dominic J. Caruso appointed as Lead Independent Director.
Price Impact
More from MCK
McKesson Q1 EPS $5.15; Sells 13% Medical-Surgical Stake for $1.25B
McKesson Q1 Adj. EPS $9.93 (+20%); Raises FY27 Guidance to $44.20-$45.00
McKesson Announces Executive Vice President Retirement, New Appointment